Preeta Ananthanarayanan

Turin, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Multimodal C9-66 CAR-T cell immunotherapy improves outcome in preclinical models of pancreatic cancer.

Multimodal C9-66 CAR-T cell immunotherapy improves outcome in preclinical models of pancreatic cancer.

Journal: Gut

Published: November 15, 2025

Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells.

Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells.

Journal: STAR protocols

Published: October 11, 2024

CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches.

CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches.

Journal: Cell reports. Medicine

Published: February 07, 2024

Gasdermin C promotes Stemness and Immune Evasion in Pancreatic Cancer via Pyroptosis-Independent Mechanism.

Gasdermin C promotes Stemness and Immune Evasion in Pancreatic Cancer via Pyroptosis-Independent Mechanism.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 22, 2023

Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity.

Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 09, 2023

Sound-based assembly of a microcapillary network in a saturn-like tumor model for drug testing.

Sound-based assembly of a microcapillary network in a saturn-like tumor model for drug testing.

Journal: Materials today. Bio

Published: February 23, 2022

SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma.

SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 12, 2021

Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma.

Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma.

Journal: International journal of molecular sciences

Published: May 31, 2020

Wnt/IL-1β/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5.

Wnt/IL-1β/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5.

Journal: International journal of cancer

Published: December 02, 2018

Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma.

Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: November 21, 2018

Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma.

Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: November 15, 2017

Enhanced effect of geldanamycin nanocomposite against breast cancer cells growing in vitro and as xenograft with vanquished normal cell toxicity.

Enhanced effect of geldanamycin nanocomposite against breast cancer cells growing in vitro and as xenograft with vanquished normal cell toxicity.

Journal: Toxicology and applied pharmacology

Published: December 01, 2016

Showing 1-12 of 12

Last Updated: 09/26/2026